Diagnostic and therapeutic compositions and methods for affecting tumor growth using oxygen mimetic agents
CA 2400092 A1 · Owner: Virexx Research, Inc. · Inventors: Noujaim, Antoine; Stewart, Michael William
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention relates generally to the use of oxygen mimetic compounds or agents to limit the growth of hypoxic tissue such as solid tumors, through , the delivery of cytotoxic agents and/or a reduction in the amount of released pro-angiogenic factors responsible for new blood vessel formation.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed February 13, 2001. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended February 13, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by February 13, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.